| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOGEN INC | 42,500 | 14,059,000 | 7.51% | ||
| 2 | GILEAD SCIENCES INC | 117,500 | 12,508,000 | 6.68% | ||
| 3 | AMGEN INC | 81,500 | 11,448,000 | 6.11% | ||
| 4 | MEDTRONIC INC | 137,500 | 8,518,000 | 4.55% | ||
| 5 | ABBVIE INC | 125,000 | 7,220,000 | 3.86% | ||
| 6 | CELGENE CORP | 75,000 | 7,109,000 | 3.80% | ||
| 7 | SELECT SECTOR SPDR TR | 100,000 | 6,391,000 | 3.41% | Put | |
| 8 | SUPERNUS PHARMACEUTICALS INC COM | 600,000 | 5,215,000 | 2.79% | ||
| 9 | ZIMMER BIOMET HLDGS INC | 50,000 | 5,028,000 | 2.69% | ||
| 10 | MERCK & CO INC | 80,000 | 4,742,000 | 2.53% | ||
| 11 | WRIGHT MEDICAL GROUP N.V. | 175,000 | 4,183,000 | 2.23% | ||
| 12 | GW PHARMACEUTICALS PLC | 50,000 | 4,043,000 | 2.16% | ||
| 13 | AERIE PHARMACEUTICALS INC | 190,000 | 3,931,000 | 2.10% | ||
| 14 | Mylan Inc | 80,000 | 3,639,000 | 1.94% | ||
| 15 | REGENERON PHARMACEUTICALS INC | 10,000 | 3,605,000 | 1.93% | Put | |
| 16 | IONIS PHARMACEUTICAL | 85,000 | 3,300,000 | 1.76% | ||
| 17 | ULTRAGENYX PHARMACEUTICAL INC COM | 57,500 | 3,255,000 | 1.74% | ||
| 18 | UNITED THERAPEUTICS CORP | 25,000 | 3,216,000 | 1.72% | ||
| 19 | Receptos Inc | 50,000 | 3,106,000 | 1.66% | ||
| 20 | Esperion Therapeutics Inc | 125,000 | 3,058,000 | 1.63% | ||
| 21 | SPECTRANETICS CORP | 115,000 | 3,056,000 | 1.63% | ||
| 22 | PFIZER INC | 100,000 | 2,957,000 | 1.58% | ||
| 23 | ENTEROMEDICS INC | 2,344,000 | 2,884,000 | 1.54% | ||
| 24 | SANOFI-ADR | 50,000 | 2,822,000 | 1.51% | Call | |
| 25 | HORIZON PHARMA PLC | 220,000 | 2,702,000 | 1.44% | ||
| 26 | AVANIR PHARMACEUTICALS INC CL | 225,000 | 2,682,000 | 1.43% | ||
| 27 | DEXCOM | 65,000 | 2,600,000 | 1.39% | ||
| 28 | WRIGHT MEDICAL GROUP NV | 85,000 | 2,576,000 | 1.38% | ||
| 29 | ALKERMES PLC SHS | 60,000 | 2,572,000 | 1.37% | ||
| 30 | TENET HEALTHCARE CORP | 42,500 | 2,524,000 | 1.35% | ||
| 31 | AMGEN INC | 17,500 | 2,458,000 | 1.31% | Call | |
| 32 | PUMA BIOTECHNOLOGY | 10,000 | 2,386,000 | 1.27% | ||
| 33 | MERCK & CO INC | 40,000 | 2,371,000 | 1.27% | Put | |
| 34 | SALIX PHARMACEUTICALS INC | 15,000 | 2,344,000 | 1.25% | ||
| 35 | AUSPEX PHARMACEUTICALS INC | 90,000 | 2,310,000 | 1.23% | ||
| 36 | CHIMERIX INC | 75,000 | 2,072,000 | 1.11% | ||
| 37 | CELLDEX THERAPEUTICS INC NEW | 150,000 | 1,944,000 | 1.04% | ||
| 38 | ENDOLOGIX INC | 182,500 | 1,935,000 | 1.03% | ||
| 39 | DYAX CORP COM CVR | 185,000 | 1,872,000 | 1.00% | ||
| 40 | BIOMARIN | 25,000 | 1,804,000 | 0.96% | ||
| 41 | Allergan plc | 10,000 | 1,782,000 | 0.95% | ||
| 42 | LA JOLLA PHARMACEUTICAL CO | 180,000 | 1,730,000 | 0.92% | ||
| 43 | NOVADAQ TECHNOLOGIES INC | 125,000 | 1,586,000 | 0.85% | ||
| 44 | ARATANA THERAPEUTICS INC COM | 150,000 | 1,506,000 | 0.80% | ||
| 45 | Arrowhead Pharma Inc | 90,000 | 1,330,000 | 0.71% | ||
| 46 | ORASURE TECHNOLOGIES INC | 175,000 | 1,264,000 | 0.68% | ||
| 47 | SYNERON MEDICAL LTD ORD SHS | 120,000 | 1,202,000 | 0.64% | ||
| 48 | IMPAX LABORATORIES INC | 50,000 | 1,186,000 | 0.63% | ||
| 49 | CELLDEX THERAPEUTICS INC NEW | 75,000 | 972,000 | 0.52% | Call | |
| 50 | FLEXION THERAPEUTICS INC COM | 50,000 | 913,000 | 0.49% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001321300-14-000010, filed 2014.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
